BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10456457)

  • 1. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
    Shen L; Villoutreix BO; Dahlbäck B
    Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
    Neese LL; Wolfe CA; Church FC
    Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor.
    Van Walderveen MC; Berry LR; Chan AK
    J Biochem; 2010 Aug; 148(2):255-60. PubMed ID: 20538715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein C and its inhibitor in malignancy.
    Suzuki K; Hayashi T
    Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the A+ helix in heparin binding to protein C inhibitor.
    Elisen MG; Maseland MH; Church FC; Bouma BN; Meijers JC
    Thromb Haemost; 1996 May; 75(5):760-6. PubMed ID: 8725720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
    van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
    Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
    Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
    Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor activator (HGFA): its regulation by protein C inhibitor.
    Suzuki K
    FEBS J; 2010 May; 277(10):2223-9. PubMed ID: 20402764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
    Chan AK; Patel S; Male C; Berry LR; Mitchell LG
    Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.
    Shen L; Dahlbäck B; Villoutreix BO
    Biochemistry; 2000 Mar; 39(11):2853-60. PubMed ID: 10715104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
    Marlar RA; Kressin DC; Madden RM
    Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
    Rezaie AR
    Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
    Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
    Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional assays for protein C activity and protein C inhibitor activity in plasma.
    Geiger M; White TM; Griffin JH
    Thromb Haemost; 1989 Feb; 61(1):86-92. PubMed ID: 2546280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
    Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
    Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin enhances the inhibition of factor Xa by protein C inhibitor in the presence but not in the absence of Ca2+.
    Sun W; Eriksson AS; Schedin-Weiss S
    Biochemistry; 2009 Feb; 48(5):1094-8. PubMed ID: 19140680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interspecies loop grafting in the protease domain of human protein C yielding enhanced catalytic and anticoagulant activity.
    Shen L; Villoutreix BO; Dahlbäck B
    Thromb Haemost; 1999 Sep; 82(3):1078-87. PubMed ID: 10494767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C.
    Yang L; Manithody C; Rezaie AR
    Biochemistry; 2002 May; 41(19):6149-57. PubMed ID: 11994010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
    Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
    Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heparin binding site of protein C inhibitor is protease-dependent.
    Li W; Huntington JA
    J Biol Chem; 2008 Dec; 283(51):36039-45. PubMed ID: 18974053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.